Clinical trials follow a protocol approved by national health
authorities and ethics committees. All ourclinical trial protocols and
outcomes (irrespective of the results), are made publicly available,
following the international reporting standard Equator (ie CONSORT).
Global standards for clinical trial activities are never
compromised and our research activities only take place in countries
where the environment, infrastructure, medical standards,
Independent Ethics Committees (IEC) or Institutional Review Boards
(IRB) are all adequate and regulated.
Doctors (investigators) must obtain free informed consent from
each participant and ensure their rights and well-being during and
after the trial. Investigators and research teams must be offered
fair reimbursement for their costs and labour. Trials must undergo
independent scientific and ethical review and approval, and are
subject to random audits by authorities during or after their execution.
For every clinical trial we sponsor, we establish safety
committees that report any adverse events on a global level to
health authorities, and who take appropriate action when required.
In addition, Bioethics Expert Groups keep track of emerging
issues, re-evaluate risks and act upon any findings. Current topics
under review include: global adherence to ethical guidelines, focus
on vulnerable populations in informed consent (especially children),
transparency in investigator-sponsored studies, use of social media
and collection of clinical data in real world evidence studies.